| Bioactivity | Dazmegrel (UK-38485) is a thromboxane synthetase inhibitor which inhibits Thromboxane A2 (TXA2) synthesis and exhibits antiplatelet vasodilator effects. Dazmegrel can be utilized in thrombosis research[1]. |
| CAS | 76894-77-4 |
| Formula | C16H17N3O2 |
| Molar Mass | 283.33 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Belch JJ, et al. Platelet changes after a saturated fat meal and their prevention by Dazmegrel, a thromboxane synthetase inhibitor. Lipids. 1987 Mar;22(3):159-62. |
Dazmegrel
CAS: 76894-77-4 F: C16H17N3O2 W: 283.33
Dazmegrel (UK-38485) is a thromboxane synthetase inhibitor which inhibits Thromboxane A2 (TXA2) synthesis and exhibits a
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.